RESULTS

m6 RNA methylation: An emerging common target in the immune response to cancer and severe acute respiratory syndrome-coronavirus-2 infection (Exp Med, 2022)

In academia-industry collaboration, Dr. Sato has focused on the emerging roles of m6A RNA modification and has noted that it could be useful not only for the early detection of cancer but also for SARS-CoV-2 screening during a global pandemic.